All In Biotech

Drug Trial Radar · NCT01728805

Study of KW-0761 Versus Vorinostat in Relapsed/Refractory CTCL

Open-Label, Multi-Center, Randomized Study of Anti-CCR4 Monoclonal Antibody KW-0761 (Mogamulizumab) Versus Vorinostat in Subjects With Previously Treated Cutaneous T-Cell Lymphoma

Last checked: Nov 20, 2026Latest source record: Apr 25, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 372 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

372

Actual

Start

Nov 2012

Primary completion

Mar 2017

Study completion Feb 17, 2021

Sponsor

Lead sponsor
Kyowa Kirin, Inc.Industry
Sponsor type
Industry
First posted
Nov 20, 2012

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to compare the progression free survival of KW-0761 versus vorinostat for subjects with relapsed or refractory CTCL.

Conditions

  • Cutaneous T-Cell Lymphoma

Interventions

  • KW-0761Biological

    1.0 mg/kg weekly x 4 in cycle 1 then every other week until progression

  • VorinostatDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Progression Free SurvivalTime frame: From date of randomization at every visit until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 36 months

Locations

73 sites in 11 countries. Site status is shown where the registry gives one.

  • University of Alabama - Birmingham

    Birmingham, Alabama

  • Banner MD Anderson

    Gilbert, Arizona

  • City of Hope National Medical Center

    Duarte, California

  • UCLA Medical Center

    Los Angeles, California

  • Stanford Medical Center

    Stanford, California

  • University of Colorado

    Aurora, Colorado

  • Yale University School of Medicine - Yale Cancer Center

    New Haven, Connecticut

  • H. Lee Moffitt Cancer Center

    Tampa, Florida

  • The Winship Cancer Institute (Emory University)

    Atlanta, Georgia

  • Northwestern University

    Chicago, Illinois

  • Indiana University

    Indianapolis, Indiana

  • University of Kansas Cancer Center

    Westwood, Kansas

  • Tulane University Medical Center

    New Orleans, Louisiana

  • Massachusetts General Hospital

    Boston, Massachusetts

  • Boston Medical Center, Department of Medicine, Section of Hem/Onc

    Boston, Massachusetts

  • Dana Farber Cancer Institute

    Boston, Massachusetts

  • University of Michigan

    Ann Arbor, Michigan

  • Washington University School of Medicine

    St Louis, Missouri

  • Dartmouth Hitchcock Medical Center

    Lebanon, New Hampshire

  • Universal Dermatology, PLLC

    Fairport, New York

  • Columbia Presbyterian

    New York, New York

  • Memorial Sloan Kettering Cancer Center

    New York, New York

  • University of Rochester School of Medicine

    Rochester, New York

  • Wake Forest Baptist Medical Center

    Winston-Salem, North Carolina

  • University Hospitals Cleveland Medical Center

    Cleveland, Ohio

  • Ohio State University

    Columbus, Ohio

  • University of Pennsylvania

    Philadelphia, Pennsylvania

  • Thomas Jefferson University

    Philadelphia, Pennsylvania

  • University of Pittsburgh School of Medicine

    Pittsburgh, Pennsylvania

  • Vanderbilt University Medical Center

    Nashville, Tennessee

  • M.D.Anderson Cancer Center

    Houston, Texas

  • Huntsman Cancer Institute

    Salt Lake City, Utah

  • University of Washington

    Seattle, Washington

  • Medical College of Wisconsin

    Milwaukee, Wisconsin

  • Westmead Hospital

    Westmead, New South Wales, Australia

  • Royal Adelaide Hospital

    Adelaide, South Australia, Australia

  • Flinders Medical Centre

    Bedford Park, South Australia, Australia

  • Parkville Cancer Clinical Trials Unit

    Melbourne, Victoria, Australia

  • Aarhus University Hospital

    Aarhus, Denmark

  • CHU de Nantes

    Nantes, France

Showing 40 of 73 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.